4
Changes in Ownership
Phreesia, Inc. Filed Acc 0001127602-25-012493
SVP, Life Sciences sold 260 shares at $23.04 ($5,991)
From the SEC's structured data for this filing
Trades in this filing
Linetsky David · SVP, Life Sciences
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2025-04-21 | Sale : show line 1 in the form | −260 | $23.04 | $5,991 | 8,752 | I |
| Open-market sales · 260 sh · avg $23.04 · $5,991 | ||||||
Loading xslF345X05/form4.xml…